Cite
Savić MP, Ajduković JJ, Plavša JJ, et al. Evaluation of A-ring fused pyridine d-modified androstane derivatives for antiproliferative and aldo-keto reductase 1C3 inhibitory activity. Medchemcomm. 2018;9(6):969-981doi: 10.1039/c8md00077h.
Savić, M. P., Ajduković, J. J., Plavša, J. J., Bekić, S. S., Ćelić, A. S., Klisurić, O. R., Jakimov, D. S., Petri, E. T., & Djurendić, E. A. (2018). Evaluation of A-ring fused pyridine d-modified androstane derivatives for antiproliferative and aldo-keto reductase 1C3 inhibitory activity. MedChemComm, 9(6), 969-981. https://doi.org/10.1039/c8md00077h
Savić, Marina P, et al. "Evaluation of A-ring fused pyridine d-modified androstane derivatives for antiproliferative and aldo-keto reductase 1C3 inhibitory activity." MedChemComm vol. 9,6 (2018): 969-981. doi: https://doi.org/10.1039/c8md00077h
Savić MP, Ajduković JJ, Plavša JJ, Bekić SS, Ćelić AS, Klisurić OR, Jakimov DS, Petri ET, Djurendić EA. Evaluation of A-ring fused pyridine d-modified androstane derivatives for antiproliferative and aldo-keto reductase 1C3 inhibitory activity. Medchemcomm. 2018 Apr 30;9(6):969-981. doi: 10.1039/c8md00077h. eCollection 2018 Jun 01. PMID: 30108986; PMCID: PMC6071935.
Copy
Download .nbib